<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01165528</url>
  </required_header>
  <id_info>
    <org_study_id>ASVtrial</org_study_id>
    <nct_id>NCT01165528</nct_id>
  </id_info>
  <brief_title>Adaptive Support Ventilation in Acute Respiratory Distress Syndrome (ARDS)</brief_title>
  <official_title>Adaptive Support Ventilation vs. Conventional Ventilation Strategy in the Management of Acute Respiratory Distress Syndrome:A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized controlled trial to be conducted in the Respiratory Intensive Care&#xD;
      Unit (RICU) of Post Graduate Institute of Medical Education And Research (PGIMER),Chandigarh.&#xD;
      The study is approved by the Institute Ethics committee. In view of lack of previous outcome&#xD;
      data in such patients, all patients requiring RICU admission for acute respiratory distress&#xD;
      syndrome(ARDS) between January 2010 and June 2011 are being enrolled in this pilot study.&#xD;
&#xD;
      The patients meeting the aforementioned criteria will randomly assigned to ventilation with&#xD;
      assist control mode ventilation (ACMV group) as per the ARDSnet strategy or adaptive support&#xD;
      ventilation (ASV group). Being the first RCT of its type, patients will be first stabilized&#xD;
      on ACMV for 1 hour to determine the adequate minute ventilation. The randomization sequence&#xD;
      will be computer generated. The assignments will placed in sealed opaque envelopes and each&#xD;
      patient's assignment was made on admission to the RICU by the attending physician. Blinding&#xD;
      of treatment is not possible.&#xD;
&#xD;
      All patients will be ventilated only by Galileo Gold ventilators (Hamilton medical systems,&#xD;
      Bonaduz, Switzerland). Patients randomized to the ACMV group will be ventilated according to&#xD;
      low tidal volume strategy of 6ml/kg with Fio2/PEEP as per ARDSnet table to achieve a&#xD;
      saturation between 88-95% with the lowest possible Fio2 to maintain plateau pressures &lt; 30&#xD;
      cms H2o and PH &gt; 7.3 with option to reduce tidal volume to 4 ml/kg and increase respiratory&#xD;
      rate to 35/ min to achieve the above said goals11.These patients will be weaned as per&#xD;
      standard protocol of spontaneous breathing trial of 30 minutes once they are recognized&#xD;
      eligible as per statement of the sixth International consensus conference on weaning.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria:&#xD;
&#xD;
      Study to include at least 40 patients admitted to RICU with diagnosis of ARDS as defined by&#xD;
      American European consensus committee in 1994.&#xD;
&#xD;
        1. Acute onset shortness of breath(&lt;7 days)&#xD;
&#xD;
        2. PaO2/FiO2 &lt; 200 mm Hg (regardless of PEEP)&#xD;
&#xD;
        3. Bilateral infiltrates on frontal chest radiograph&#xD;
&#xD;
        4. &lt;18 mm Hg when measured or no clinical evidence of left atrial hypertension&#xD;
&#xD;
      Exclusion criteria:&#xD;
&#xD;
        1. Age less than 12 years&#xD;
&#xD;
        2. Patients having underlying chronic lung disease (COPD, interstitial lung disease,&#xD;
           pulmonary hypertension)&#xD;
&#xD;
        3. Contraindication to permissive hypercapnea (raised intracranial pressure, acute&#xD;
           cerebrovascular disorders, acute or chronic myocardial ischemia, right ventricular&#xD;
           failure, uncorrected severe metabolic acidosis, sickle cell anemia, tricyclic&#xD;
           antidepressant overdose, pregnancy)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>up to 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of ICU stay</measure>
    <time_frame>up to 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of hospital stay</measure>
    <time_frame>up to 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ease of use of ventilator mode</measure>
    <time_frame>up to 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of blood gas analysis</measure>
    <time_frame>up to 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Respiration, Artificial</condition>
  <condition>Respiratory Distress Syndrome, Adult</condition>
  <arm_group>
    <arm_group_label>Adaptive support ventilation in ARDS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients of ARDS will be randomized to this arm to receive mechanical ventilation as per ASV protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional ventilation strategy in ARDS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>type of mechanical ventilation</intervention_name>
    <description>patients are randomized to receive one of the two types of mechanical ventilation for ARDS</description>
    <arm_group_label>Adaptive support ventilation in ARDS</arm_group_label>
    <arm_group_label>conventional ventilation strategy in ARDS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Acute onset shortness of breath(&lt;7 days)&#xD;
&#xD;
          -  PaO2/FiO2 &lt; 200 mm Hg (regardless of PEEP)&#xD;
&#xD;
          -  Bilateral infiltrates on frontal chest radiograph&#xD;
&#xD;
          -  &lt;18 mm Hg when measured or no clinical evidence of left atrial hypertension&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 12 years&#xD;
&#xD;
          -  Patients having underlying chronic lung disease&#xD;
&#xD;
          -  Contraindication to permissive hypercapnia (raised intracranial pressure, acute&#xD;
             cerebrovascular disorders, acute or chronic myocardial ischemia, right ventricular&#xD;
             failure, uncorrected severe metabolic acidosis, sickle cell anemia, tricyclic&#xD;
             antidepressant overdose, pregnancy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arjun srinivasan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>dept of pulmonary medicine &amp; critical care, PGIMER</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Respiratory intensive care unit, PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ritesh Agarwal, MD, DM, MAMS, FCCP</last_name>
      <phone>9914209825</phone>
      <phone_ext>2756825</phone_ext>
      <email>riteshpgi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Arjun Srinivasan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <study_first_submitted>July 16, 2010</study_first_submitted>
  <study_first_submitted_qc>July 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2010</study_first_posted>
  <last_update_submitted>July 19, 2010</last_update_submitted>
  <last_update_submitted_qc>July 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Arjun Srinivasan, senior resident</name_title>
    <organization>Dept of Pulmonary medicine &amp; critical care, PGIMER</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

